Efficacy and Safety of Sarilumab in COVID-19: A Systematic Review
Background. It has been found that there is overactivation of immune response in patients with COVID-19. Several studies are going on to assess the role of immunomodulation. IL-6 antibodies such as tocilizumab have been found to have efficacy in the treatment of COVID-19. We aim to assess the role o...
| Published in: | Interdisciplinary Perspectives on Infectious Diseases |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Online Access: | http://dx.doi.org/10.1155/2021/8903435 |